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ABSTRACT
Free intracellular calcium ([Ca21]i), in addition to being an
important second messenger, is a key regulator of many cellular
processes including cell membrane potential, proliferation, and
apoptosis. In many cases, the mobilization of [Ca21]i is controlled
by intracellular store activation and calcium influx. We have
investigated the effect of several ion channel modulators, which
have been used to treat a range of human diseases, on [Ca21]i
release, by ratiometric calcium imaging. We show that six such
modulators [amiodarone (Ami), dofetilide, furosemide (Fur), mi-
noxidil (Min), loxapine (Lox), and Nicorandil] initiate release of
[Ca21]i in prostate and breast cancer cell lines, PC3 and MCF7,
respectively.Whole-cell currents in PC3 cells were inhibited by the
compounds tested in patch-clampexperiments in a concentration-
dependent manner. In all cases [Ca21]i was increased by mod-
ulator concentrations comparable to those used clinically. The
increase in [Ca21]i in response to Ami, Fur, Lox, and Min was
reduced significantly (P , 0.01) when the external calcium was
reduced to nM concentration by chelation with EGTA. The data
suggest that many ion channel regulators mobilize [Ca21]i. We
suggest amechanismwhereby calcium-induced calcium release is
implicated; such amechanismmaybe important for understanding
the action of these compounds.
Introduction
A number of ion channel modulators are used for the
treatment of diseases ranging from cardiac arrhythmia to
psychosis (Delisle et al., 2004). Although many modulators
have been studied for their pharmacological properties,
surprisingly little information is available on the role they
may play in the availability of free intracellular calcium
([Ca21]i), which is critical for cell function (e.g., proliferation,
apoptosis, and gene regulation) (Berridge et al., 2000). [Ca21]i
also acts as an intracellular transducer for extracellularly
activated signaling (e.g., the Wnt signaling pathway)
(Thrasivoulou et al., 2013). [Ca21]i release due to the action
of commonly used drugs in different cell types may provide
clues regarding some side effects of these compounds. For
example, antihypertensive drugs lower the levels of [Ca21]i in
erythrocytes (Baumgart et al., 1986). Epidemiologic studies
indicate that patients on antihypertensive drugs have a lower
incidence of cancer progression and mortality for breast, skin,
and prostate cancers (Barron et al., 2011; Lemeshow et al.,
2011; Melhem-Bertrandt et al., 2011; Grytli et al., 2013).
In this work, we decided to concentrate on six commonly
used clinical compounds, namely, amiodarone (Ami), dofetilide
(Dof), furosemide (Fur), minoxidil (Min), loxapine (Lox), and
nicorandil (Nic) to investigate their role in [Ca21]i release in
prostate and breast cancer cells. These drugs act as antihyper-
tensives, antiarrhythmic, vasodilator, and diuretic, by modu-
lating ion channels and transporters.
We performed a series of experiments to investigate the role
of these modulators as inhibitors of cellular pathways. By
using electrophysiology and live cell calcium imaging we
discovered that Ami, Dof, Fur, Min, Lox, and Nic alter
whole-cell currents and activate [Ca21]i stores in cancer cells
(PC3, prostate cancer cell line; MCF7, breast cancer cell line).
Most of these compounds increase [Ca21]i release with distinct
kinetics via calcium-induced calcium release (CICR) (Bootman
et al., 2002) dependent and independent mechanisms. Our
results reveal a novel mechanism of action of numerous ion
channelmodulators that have the potential ofmanipulating the
magnitude and duration of free [Ca21]i changes in mammalian
cells in vitro.
Materials and Methods
Compounds. Stock solutions were prepared in phosphate-
buffered saline (without Ca21 or Mg21 pH 7.4, Gibco ThermoFisher:
Loughborough, UK). All compounds used in live [Ca21]i experiments
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(Ami hydrochloride, Dof, Fur, Min, Lox succinate salt, and Nic) were
purchased from Sigma-Aldrich (Dorset, UK) and dissolved in dime-
thylsulfoxide (DMSO) ReagentPlus (Sigma-Aldrich). The systematic
names of the compounds are as follows: Ami hydrochloride: 2-butyl-3-
benzofuranyl)[4-[2-(diethylamino)ethoxy]-3,5-diiodophenyl]methanone
hydrochloride; Dof: N-[4-[2-[Methyl[2-[4-[(methylsulfonyl)amino]-
phenoxy]ethyl]amino]ethyl]phenyl]methanesulfonamide; Fur:
4-chloro-N-furfuryl-5-sulfamoylanthranilic acid; Min: 6-(1-Piperidinyl)-2,4-
pyrimidinediamine 3-oxide; Lox succinate salt: 2-Chloro-11-(4-methyl-1-
piperazinyl)dibenzo[b,f][1,4]oxazepine and 1,4-Butanedioic acid; andNic:
2-(Pyridine-3-carbonylamino)ethyl nitrate (also see the Supplemental
Material for the structures).
Cell Culturing. The cell lines used (PC3, prostate cancer; MCF7,
breast cancer) were obtained from ATCC (American Type Culture
Collection, Middlesex, UK). The protocols used to culture these have
been described elsewhere (Thrasivoulou et al., 2013). Briefly, cells
were cultured in RPMI Medium 1640 (Gibco) supplemented with
5 mM L-glutamine and fetal bovine serum (10%). Dissociated cells
were plated in filtered, 25-cm2 Nunc EasYFlask (Thermo Scientific:
Loughborough, UK) at a plating density of 105 cells/flask. Dissociation
of cells was achieved by treating the cells for 3 minutes with 1 ml of
trypsin (2.5%)/versene (ratio 1:9, Gibco) incubated at 37°C. Cells were
maintained at 37°C in a humidified 5% CO2 atmosphere and 21% O2.
High-Throughput Electrophysiology. Experiments were per-
formed using the QPatch single-hole and QPatch multihole technol-
ogies with QPlate (Biolin-Sophion: Ballerup, Denmark). The QPlate
contains 16 or 48 individual patch-clamp sites that are operated
asynchronously and in parallel. PC3were cultured and harvested using
Detachin and kept in the QStirrer (Biolin-Sophion) on the QPatch prior
to the automatic preparation. The intracellular solution contained (in
mM concentrations): CaCl2 5.3, MgCl2 1.7, EGTA 10; HEPES 10; KCl
120 and Na2-ATP 4; pH 7.2 with osmolarity of 295 mOsm. The
intracellular solution is thus calculated to contain 680 nM free calcium.
The extracellular solution contained CaCl2 2, MgCl2 1, HEPES 10, KCl
4, and NaCl 145; pH 7.4 with osmolarity adjusted to 285–295 mOsm.
Subsequent to the cell suspension being transferred from the
QStirrer to the QPlate, a pressure of 270 mBar was applied to obtain
positioning and sealing of the cells. Awhole-cell protocol with pressure
pulses at 2150 mBar was used to obtain whole-cell formation.
Thereafter, the membrane was clamped at 290 mV between execu-
tions of the voltage protocols.
The intracellular solutions and compounds were applied by eight
pipettes. PC3 cells were kept in culture medium in the QStirrer for up
to 4 hours. Prior to testing, the cells were transferred to the QFuge
(Biolin-Sophion), spun down, and washed in Ringer’s solution twice
before being applied to the measuring site in the QPlate. Gigaseals
were formed upon execution of a combined suction/voltage protocol.
Further suction led to establishment of the whole-cell configuration.
Solutions and compounds were applied through the glass-coated flow
channels in the QPlate. Currents were recorded using a command
ramp from2120 to1120mV at 0.5mV/ms every 3 seconds. Data were
sampled at 5 kHz and filtered using a fourth-order Bessel filter.
The IC50 values were calculated using a Hill equation fit to the
average currents (Ic) in a single experiment as the concentrationswere
increased. Thus
Ic5 Ib1

If - Ib

×
n
ðc=iec50Þh
.h
11 ðc=iec50Þh
io
where Ib and If is the baseline and final response current levels,
respectively; iec50 is the IC50 or EC50 value; h is the Hill coefficient;
and c is the compound concentration. A Levenberg-Marquardt
minimization was used to fit the parameters.
Intracellular Calcium Imaging. [Ca21]i imaging was performed
as described elsewhere (Thrasivoulou et al., 2013). Cells were grown
as a monolayer in 35-mm FluoroDish (World Precision Instruments:
Hertfordshire, UK) in 3 ml of culture medium for 60–80 hours prior to
imaging. Fluorescent Ca21 indicators FuraRed and Fluo-4 (Invitrogen
ThermoFisher: Loughborough, UK) were loaded in the FluoroDish
30 minutes before imaging and incubated at 37°C. Both fluorescent
indicators were added at 1 mg/ml (∼1.3 mM) after removing 2 ml out of
3 ml of medium in the FluoroDish. Prior to imaging, the FluoroDish
was washed with phosphate-buffered saline (2) and replaced with
1 ml of fresh phosphate-buffered saline. Live [Ca21]i imaging was
performed on an Olympus FluoView 1000 confocal microscope using a
20 dry objective (numerical aperture 0.75) at 37°C. Fluorescent Ca21
indicators were excited with an argon laser line (488 nm), and
emissions were recorded in the green channel (500–560 nm) for
Fluo-4 and in the red channel (600–700 nm) for FuraRed. Image and
dataacquisitionwasperformedusingFluoView1000 software (Olympus:
Essex, UK). Fluorescent intensity was measured and data exported
as a tab-delimited file and in an Excel file format for further analysis
using Wolfram (Oxfordshire, UK) Mathematica 10.3 (Supplemental
Fig. 1), MedCalc (version 13.1.2 Ostend, Belgium), and OriginPro
2015 (OriginLab Northampton, MA) software.
Free Calcium Measurements in Solutions. Since imaging
experiments were carried out in nominally zero calcium solutions,
calcium ion measurements were made using a B-751 LAQUAtwin
compact calcium ion meter (Horiba Kyoto, Japan), calibrated using
standard calcium solutions (provided by themanufacturer) in the one-
point calibration in low concentration mode. The experiments were
repeated with different batches of solutions over different days. When
chelated by EGTA, free calcium was reduced to ,10 nM at 37°C.
Data Analysis and Statistics. The kinetics of free [Ca21]i (e.g.,
time constants for rise, dwell, and fall times) were calculated using
analysis described previously (Thrasivoulou et al., 2013). Briefly, from
the baseline of the signal to the highest point of the peak, two parallel
lines were placed on the 10% and 90% y-axis of the peak. This creates
four interception points on the waveform. The rise time is defined as
the time from the first point to the second point, the dwell time is
similarly defined as the time from the second point to the third point,
and the fall time is defined as the time from the third point to the
fourth point. The data acquired from the FuraRed andFluo-4 channels
were exported from the FluoView 1000 software and the Fluo-
4/FuraRed ratio was calculated. Fluo-4 is not fluorescent unless bound
to Ca21 and used as an indicator for ([Ca21]i; FuraRed fluorescence
decreases once bound to Ca21. The two indicators have reciprocal
shifts in intensity due to calcium binding and are used together in a
ratiometric probe strategy. The time-series data were then plotted
using Origin 2015 software (OriginLab) and used as the basis for
measurements on the kinetics of calciummobilization. The rise, dwell,
and fall times were calculated as described elsewhere (Wang et al.,
2010; Thrasivoulou et al., 2013). Statistical analysis was performed
using the Mann-Whitney U test using the MedCalc software (version
15.8). For some experiments, Wolfram Mathematica 10.3 (used for
Supplemental Fig. 1) was programmed to analyze the data automat-
ically using the samemethods for the peak analysis and time-constant
calculations as were used with Origin.
Results
Electrophysiological Properties of Compounds on
Whole-Cell Currents in PC3 Cells. The electropharmacol-
ogy of a number of compounds has been described with IC50
concentrations in the micromolar range for the modulation
of endogenous currents, largely for antiarrhythmic function
in cardiac cells (Leblanc et al., 1989; Rasmussen et al., 1992;
Satoh, 1993; Kodama et al., 1997; Desai et al., 2000;
Thümmler et al., 2007; Biton et al., 2012) but also for some
other cell types (Desai et al., 2000) including cell lines over-
expressing specific ion channel proteins (Thümmler et al.,
2007) (summarized in Supplemental Table 1). We first
established a concentration dependence for the inhibition of
endogenous currents in PC3 cells using a multipatch system
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(QPatch, see Material and Methods) using five different con-
centrations of the compounds.
Figure 1 shows currents at a range of potentials elicited in
whole-cell clamped PC3 cells using a ramp command potential
(from 2120 to 1120 mV). All compounds inhibited whole-cell
endogenous currents in PC3 cells by 25%–70%. The mean
inward current at 2100 mV was inhibited by 69% by 33 mM
Lox (n5 5), by 57% by 50mMDof (n5 4), by 30% by 50mMMin
(n5 3), and by 61% by 50mMNic (n5 3). At positive potentials
(e.g., 1100 mV) the inhibition of the whole-cell current was
relatively less (between 24% and 50%). The results indicate
that there exists an inhibitable inwardmovement of cations at
more negative potentials.
The data show no indication of pronounced voltage de-
pendence to the inhibition. To establish the concentration
dependence of inhibition, the endogenous currents were
measured at 1120 mV (Fig. 2) and at 270 mV. The IC50
values for the six compounds used ranged between 10 and
300 mM. These results indicate that endogenous currents in
PC3 cells are modulated by the six compounds tested. Based
on these experiments we used 50 mM as the concentration for
most of the compounds tested for [Ca21]i release experiments.
[Ca21]i Release in Response to Ion Channel Activity
Modulating Compounds. Addition of the tested compounds
to the extracellular solution caused a change in the ratio of
Fluo-4/FuraRed in PC3 cells (Fig. 3; Supplemental Material).
When the ratio of Fluo-4/FuraRedwas plotted against time, the
free [Ca21]i rise induced by all compounds can be described as
having a distinct rise from the baseline, dwelling in the
plateau phase, and returning back to the baseline (Fig. 4). This
waveform was used to measure the amplitude and kinetics of
the activation of [Ca21]i in PC3 cells in response to Ami, Dof,
Fur, Min, Lox, and Nic. The amplitude of the calcium signal
varied between the compounds with Min, Ami, and Lox
demonstrating the highest amplitude and Fur, Nic, and Dof
demonstrating relatively low amplitude (Fig. 5). The amplitude
Fig. 1. Representative current-voltage (I-V) curve of 3–6 independent cells is shown. Single cells were placed in a QPatch plate (see Materials and
Methods) and recorded in a whole-cell configuration. A voltage ramp of2120 to +120 mV was executed every 3 seconds. Current-voltage characteristics
of control (gray lines) and with drugs (colored lines). (A) Lox (orange) at 33 mM, (B) Dof (blue) at 50 mM, (C) Nic (green) at 50 mM, and (D) Min (red) at
50 mM (similar experiments were performed for Ami and Fur, data not shown). All compounds tested inhibited the whole-cell current at negative and
positive potentials by 25%–70% of the control.
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of calcium release in PC3 cells for Ami, Dof, Fur, Lox, Min,
and Nic were 2 6 0.2, 1 6 0.1, 1.2 6 0.1, 1.5 6 0.2, 1.7 6 0.2,
and 1.2 6 0.1 (mean 6 S.E.M., n 5 30–78 cells from 4 to
10 individual experiments), respectively, relative to a base-
line of 1.0. The [Ca21]i release in response to these com-
pounds was also concentration dependent (Fig. 6). In addition,
all compounds induced a [Ca21]i rise in MCF7 cells, a breast
cancer cell line (Supplemental Fig. 2; Supplemental Mate-
rial). Thus, the phenomenon was not specific to the PC3 cell
line only.
We have previously observed that DMSO, the vehicle used
to dissolve organic compounds such as thapsigargin (Thastrup
et al., 1990) or those used in this study, can induce [Ca21]i
release in PC3 cells (Thrasivoulou et al., 2013) in addition
to other cell types (Morley and Whitfield, 1993). This was
the case here (Fig. 4; Supplemental Fig. 2). To limit the
contamination of the [Ca21]i signal by the effects of DMSO two
strategies were adopted:
1. The [Ca21]i release by experimental compound dissolved
in DMSO was investigated in the same cell following
exposure to DMSO alone [similar to Thrasivoulou
et al. (2013) and Morley and Whitfield (1993)]. When
this control was used, there was a relatively small
[Ca21]i release after exposure to DMSO alone (e.g.,
Ami, Supplemental Fig. 3).
2. Ethanol and methanol were used as the solvent instead
of DMSO. For example, when Lox or Fur were
dissolved in ethanol or methanol (Supplemental Figs.
4 and 5), the [Ca21]i release was similar to that
observed when these compounds were resuspended in
DMSO. Such controls indicate that [Ca21]i release is
induced by the compounds with minimal, if any,
contribution from the effects of DMSO and that the
DMSO-induced [Ca21]i occurs by a different mecha-
nism than those induced by the compounds used in this
study.
Fig. 2. Concentration dependence of the inhibition of endogenous currents using QPatch in PC3 cells by compounds used in this study. A voltage ramp
was employed to measure currents in PC3 cells using the QPatch system (seeMaterials andMethods). Peak currents with and without the compounds at
120 mV were used to construct concentration dependence of the inhibition of the currents. Each graph represents a single cell; IC50 values were
calculated using the data represented previously. The x-axis for each compound is found below each condition’s graphs as a scale bar (mM).
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Kinetics of [Ca21]i Release: Rise, Dwell, and Fall
Times. The waveform was characterized by three con-
stants: rise time (the time needed to reach maximum
amplitude), dwell time (the time the signal stays at the
peak), and fall time (the time needed for the signal to fall
from the peak back to the baseline), according to criteria
described previously (Thrasivoulou et al., 2013). The time
constants indicate that the [Ca21]i release characteris-
tics varied significantly between the compounds tested
(Fig. 7, A–C). For example, the free [Ca21]i release by Dof
demonstrates a relatively low amplitude and long duration
(Figs. 4, 6, and 7B). Min and Dof displayed the slowest rise
and fall times, as well as the longest dwell time (Fig. 7, A–C).
A principal component analysis of the compounds based on
the dwell time characteristics of [Ca21]i indicated that these
drugs showed three components withmost drugs segregating
into two components (Fig. 7D). These results indicate that
Min and Dof induce slow exhaustion and replenishments of
the free [Ca21]i stores. Dof had the slowest rise, dwell, and fall
times.
Fig. 3. Snapshots of PC3 cells labeled with calcium
indicators Fluo-4 (green) and FuraRed (red), of four time
points (A–D) at t = 0, 281, 288, and 492 seconds. At t =
0 seconds (A), steady state, baseline; at t = 281 seconds (B)
approximately 50% of cells undergoing a calcium release; at
t = 288 seconds (C) calcium signal during the peak of the
response; and at t = 492 seconds (D) after the calcium
response has ended the signal returns to baseline. The
diffusion constant has been previously measured as 0.21
mm/second. Scale bar = 10 mm.
Fig. 4. Representative traces of intracel-
lular calcium release in PC3 cells in
response to addition of 50 mM concentra-
tion of compounds (green, Ami; orange,
Min; red, Lox; pink, Fur; gray, Dof; blue,
Nic; and black, DMSO). The y-axis is
the ratio of Fluo-4/FuraRed channels
(unbound calcium/bound calcium, respec-
tively) in arbitrary units. The mean ampli-
tude and time constants of each compound
were used to select a representative trace
with similar characteristics. Number of
independent experiments n = 5–8 per
compound; 30–80 single cell measure-
ments per compound.
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The characteristics of rise, dwell, and fall times seemed to
follow a specific pattern for any given compound, e.g., a
reagent that has a fast rise time, would also have a short
dwell time and fast fall time or vice versa. Unlike the other
compounds used, Nic is an activator of K1 channels (Kukovetz
et al., 1992). The [Ca21]i waveform for Nic was relatively small
and similar to that of DMSO, both in amplitude and duration
(Figs. 4 and 7B). In some experiments, Nic-induced [Ca21]i
release was measured soon after application of DMSO in the
same cells and the results were similar to those found in Fig. 4,
indicating that it is distinguishable from that of DMSO. The
dwell times could be categorized into short (Ami and Lox), long
(Min and Fur), and very long (Dof). Time constants and
amplitude were also calculated for MCF7 cells (Supplemental
Fig. 6).
Control of Drug-Induced [Ca21]i by Extracellular
Calcium. In the majority of our live calcium imaging exper-
iments, we used nominally calcium free extracellular solu-
tion to investigate [Ca21]i release; the external calcium was
estimated to exceed 70 mM due to impurity contamination
from other salts. The measured Ca21 in the extracellular
solution, in the so-called Ca21-free solutions, was found to be
62.3 6 8.2 mM (n 5 30 from three batches).
It is known that in certain circumstances [Ca21]i release can
be triggered by entry of very small amounts of Ca21 from
outside, via the opening of calcium channels, to initiate amuch
larger increase of free [Ca21]i by a CICRmechanism (Bootman
et al., 2002). CICR has been described in many cell types
including striated muscle (Endo et al., 1970; Fabiato, 1983;
Endo, 2007) and nonmuscle cells (Verkhratsky and Shmigol,
1996). Even entry from submicromolar levels of extracellular
calcium can be sufficient to activate CICR pathways (Berridge
et al., 2003; Endo, 2009).
Therefore, we hypothesized that at least one pathway
throughwhich the present drugs activated intracellular stores
was via CICR. To test this hypothesis we reduced free calcium
in the extracellular solution with 5 mM EGTA. The resulting
calculated level of calcium was then less than ,10 nM. The
amplitude of the [Ca21]i signal in the presence of EGTA was
significantly reduced in most of our compounds (Fig. 8). These
results indicate that a CICR mechanism may be operating to
activate intracellular Ca21 stores in response to the applica-
tion of drugs. Live calcium imagingwas also performed on PC3
cells, pretreated with the calcium channel blocker nifedipine
prior to addition of compound Min or Lox. The drug-induced
[Ca21]i release was inhibited by nifedipine (Supplemental
Fig. 7). The results are similar to those observed when EGTA
was added to the extracellular solution, further indicating
that the drug-induced [Ca21]i release is facilitated by extra-
cellular calcium.
Discussion
In this study, we demonstrated that Ami, Dof, Fur, Min,
Lox, and Nic (see Supplemental Fig. 8 for the molecular
structures of the compounds) give rise to a [Ca21]i signal in
PC3 prostate cancer cell lines and in MCF7 breast cancer cell
lines. To our knowledge this is the first report of these
compounds acting on [Ca21]i in cancer cells.
Ami (a benzofuran derivative, class III anti-arrythmic, and
K1 channel blocker) has been used to treat tachycardias
(Kodama et al., 1997); it is known to induce intracellular
calcium alterations in fungi (Gupta et al., 2003; Courchesne
et al., 2009). Dof, another antiarrhythmic, selectively inhibits
the rapid component of hERG/IKr K
1 current (Rasmussen
et al., 1992). Fur, a sulfamoylanthranilic acid derivative and
diuretic inhibits Na-K-Cl cotransporter (Haas, 1989). BothNic
and Min act on adenosine triphosphate–sensitive K1 (KATP)
channels (Taira, 1989; Edwards and Weston, 1990) and are
used as vasodilators; Min is further used to stimulate hair
growth and induces intracellular calcium release in dermal
papilla cells (Li et al., 2001). Lox, an antipsychotic drug,
activates Slack channels (Biton et al., 2012) and inhibits
mechanosensitive ion channels (e.g., KCNK2) (Thümmler
et al., 2007) (see Supplemental Table 1). The role of calcium
in cell proliferation and apoptosis in both cancer and immune
cells (Schwarz et al., 2013) indicates that modulation of in-
tracellular calcium processes may present a potential thera-
peutic action of the compounds used in this study and would be
a useful tool in cancer research.
Fig. 5. Concentration dependence of the intracellular calcium release
using live calcium imaging. Box plots of Lox, Min, and Fur. The x-axis is
the concentration (mM) and the y-axis is the amplitude of the waveforms in
arbitrary units (A.U.).
Fig. 6. Box plots of the amplitude of the calcium waveform. Amplitude
measurements at the peak of the response with the addition of each
compound (50 mM) to PC3 cells (n = 30–78 cells per compound). Statistical
significance was calculated using a Mann-WhitneyU test. The amplitude is
measured in arbitrary units (A.U.). Number of independent experiments n =
5–8 per compound; 30–80 single cell measurements per compound.
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Since the measured signal was sensitive to the external
level of free calcium we propose that a novel mechanism for
[Ca21]i release by Ami, Fur,Min, and Lox is a CICR-facilitated
mechanism as evidenced by the live calcium imaging re-
sults (Fig. 8). The compounds tested have a variety of clinical
applications, including vasodilation, antiarrhythmics, and
diuretics. They exert their therapeutic actions by interacting
mainly with potassium channels and other ion transporters.
The current literature describes a number of receptor inter-
actions for each compound individually but fails to make any
connection with any [Ca21]i release (Edwards and Weston,
1990; Nattel et al., 1992; Rasmussen et al., 1992; Yamada
et al., 1997; Lee et al., 2007; Biton et al., 2012). A general
feature of calcium signaling is how different calcium signals
can be translated into specific cell functions depending on
their amplitude and duration; the type of signal may result in
different functions such as proliferation, apoptosis, and
tolerance (Bandyopadhyay et al., 2007; Qu et al., 2011).
The electropharmacology of the compounds tested indicates
that there is an inhibition of currents evoked at both nega-
tive and positive potentials (Figs. 1 and 2). Most of these
compounds have been investigated for their electrophysio-
logical properties either in cells overexpressing ion channels
(Yamada et al., 1997; Thümmler et al., 2007) or in neurons
and cardiac cells (Leblanc et al., 1989; Rasmussen et al.,
1992; Satoh, 1993; Kodama et al., 1997; Desai et al., 2000;
Thümmler et al., 2007; Biton et al., 2012). Very little is known
about how these drugs influence the electrical properties of the
cell membrane in prostate or other cancer cell lines. Our primary
motivation in investigating the electrophysiological properties of
Fig. 7. Box plots for time constants of the calcium waveform. The time constants [(A) rise, (B) dwell, and (C) fall times] were calculated from the calcium
waveform generated by the addition of each compound (50 mM) to PC3 cells. Min, Ami, Nic, Dof, Lox, and Fur labels indicated. A principal component analysis
was performed on the dwell time constants and a loading plot (D) is shown. On the basis of this, three components are identified with a majority of drugs
segregate into two components. For (A–C) the number of independent experiments wasn = 5–8 per compound; 30–80 single cell measurements per compound.
Fig. 8. Effect of reducing extracellular calcium with EGTA. When EGTA
reduced the external calcium to,10 nM [in phosphate-buffered saline (PBS)]
the response was reduced. Control solution, PBS; [Ca2+] = 62.3 mM 6 8.2);
y-axis amplitude in arbitrary units (A.U.).Number of independent experiments
per compound: n = 3 to 4; 55–205 single cell measurements per compound.
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the modulation of whole-cell currents by the high-throughput
approach was to set a baseline and identify a range of
concentrations for [Ca21]i assays in PC3 cells.
Intracellular cytosolic calcium concentration levels can in-
crease from a variety of routes. Most routes involve membrane-
bound ion channel transporters, which promote calcium
influx. A key observation in our study is that the [Ca21]i rise
induced by the compounds tested here must be via release
from internal stores via CICR once calcium enters the cell
(Fig. 9) since chelation of external calcium significantly
reduces the response (between 60% and 100%). Routes for
calcium entry via the membrane include specific calcium
channels as well as through nonspecific cation channels that
have significant calcium permeability. Such channels include
members of the transient receptor potential family, some of
which are known to be expressed in cancer cell lines (Nilius
and Owsianik, 2010).
An estimate of the flux through such channels can be
obtained from the I-V curves of Fig. 1. Although there is
little sign of the potential dependence expected for a
voltage-gated calcium channel, the inward currents mea-
sured at 2100 mV in control cells suggest typical standing
conductance of 2.7 nS (n 5 15). This is equivalent to a cell
input resistance of 380 MV, and the presence of about
100 cation-permeable transient receptor potential chan-
nels. Depending on the cell volume around the calcium
stores into which external Ca21 would flow, it is plausible
that even such a number of calcium entry sites could lead to
the CICR signal observed. However, it is also plausible,
comparing the live calcium imaging and electrophysiology
data (Figs. 8 and 1, respectively) that there may be in-
dependent inhibition of the whole-cell currents by the
compounds tested as well as an interdependent CICR-
mediated mechanism of [Ca21]i.
Fig. 9. Model for drug-induced [Ca2+]i release via a CICRmechanism. We propose that binding of compounds such as Ami (shown), Fur, Lox, and Min bind to
membrane protein receptors and initiate activation of the Ca2+ channel. Entry of external Ca2+ (dark green) into the cell depolarizes the cell electrical potential
that activates intracellular Ca2+ (light green) stores (e.g., in the endoplasmic reticulum). This activates release of [Ca2+]i from the stores; Ca
2+ release in the
cytosol in response to the drugs can be seen in Fig. 3 and the Supplemental Material. The free cytosolic Ca2+ then enters the nucleus.
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Other possible contributory routes are the ones involving
membrane-bound receptors that act on [Ca21]i intracellular
stores with the help of secondary messengers. The main
calcium store in most nonstriated cells is the endoplasmic
reticulum. The major calcium flux channels located on the
endoplasmic reticulum are the ryanodine receptors (Otsu
et al., 1990) and inositol 1,4,5-triphosphate receptors (Nixon
et al., 1994). Calcium is also stored in the mitochondria,
sarcoplasmic reticulum (muscle cells only), and nuclear
envelop; they also have to be taken into consideration as a
possible source of the Ca21 signal observed. Calcium mobili-
zation from intracellular stores has been known to occur due to
elevation of inositol triphosphate (IP3) levels via the IP3/
diacyglycerol pathway (Nakamura et al., 2000; Berridge,
2012). G protein-coupled receptors activate phospholipase
C, which in turn hydrolyses PIP2 to form IP3 and diacyglycerol.
IP3 then binds to the IP3 receptor (a calcium channel) on the
endoplasmic reticulum, releasing calcium into the cytoplasm.
Amihas been shown to be a direct activator ofGprotein-coupled
receptors; thus, this is a plausible route of the signal induced by
this compound, resulting in calcium release.
There is little evidence in the literature to suggest that the
other compounds used in this study are linked to activation of G
protein-coupled receptors. There are a largenumber ofGprotein-
coupled receptors (Gaq, Ga11, Ga14, Ga15, and Gbg) and
protein tyrosine kinase receptors that are coupled to different
phospholipase C isoforms (PLCb1-4, PLCg1-2, PLCd1-4, and
PLC«), which are able to generate [Ca21]i mobilization through
IP3 (Berridge, 2012). The duration, intensity, and type of calcium
flux seen in different cell types may regulate different Ca21-
dependent cellular functions, such as proliferation and motil-
ity (Berridge et al., 2000). For example, studies in T cells show
that different Ca21 signals can be translated into specific
transcription factor profiles, which may cause the cells to
undergo apoptosis, to proliferate, or to increase their tolerance
to environmental stress (Macián et al., 2002; Bandyopadhyay
et al., 2007; Qu et al., 2011). The focus of our future studieswill
be to examine what effects these compounds have on the
transcriptional profile of cancer cells and pinpoint the recep-
tors and downstream pathways responsible for the Ca21 flux
we have observed in this study, with the aim of creating a set of
biologic tools for manipulating intracellular calcium dynamics
to selectively control cell proliferation or cell death.
In summary, we have shown for the first time that exposure
to various ion channel activity regulators causes a release of
[Ca21]i with distinct characteristics of rise, dwell, and fall time
constants. We further show that a possible mechanism for the
drug-induced [Ca21]i release is via CICR (Fig. 9). We believe
that the data presented here show a novel cellular function for
these known ion channel regulators and may have implica-
tions on the actions and side effects of these drugs that have
been in clinical use for some time.
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